Market Tracker

04/26 2:42pm ET

Mesoblast Ltd (NASDAQ:MESO)

5.62
Delayed Data
As of 2:20pm ET
 +0.08 / +1.44%
Today’s Change
4.74
Today|||52-Week Range
12.50
-3.77%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close5.54
Today’s open5.60
Day’s range5.58 - 5.71
Volume20,980
Average volume (3 months)59,864
Market cap$633.8M
Data as of 2:20pm ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)-1,605.50%
Earnings growth (this year)+57.06%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)-95.31%
P/E ratioNM
Price/Sales322.85
Price/Book1.12

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp+0.20+1.08%
RTIXRTI Surgical Inc0.000.00%
SIENSientra Inc+0.48+3.70%
OFIXOrthofix Internation...+1.42+2.38%
Data as of 2:42pm ET, 04/26/2018

Financials

Next reporting dateMay 7, 2018
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$1.9M
Annual profit (last year)-$76.8M
Net profit margin-3,951.39%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts